上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02607 上海医药

未开盘 12-15 16:08:35

11.850

-0.100

-0.84%

最高11.970	最低11.820	成交量109.95万
今开11.920	昨收11.950	日振幅1.26%
总市值439.40亿	流通市值108.91亿	总股本37.08亿
成交额1,308万	换手率0.12%	流通股本9.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":11.85,"timestamp":1765786115008,"preClose":11.95,"halted":0,"volume":1099500,"delay":0,"floatShares":919072704,"shares":3708000000,"eps":1.3578174378545802,"marketStatus":"未开盘","change":-0.1,"latestTime":"12-15 16:08:35","open":11.92,"high":11.97,"low":11.82,"amount":13084850,"amplitude":0.012552,"askPrice":11.85,"askSize":5000,"bidPrice":11.84,"bidSize":9900,"shortable":3,"etf":0,"ttmEps":1.689423601391472,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":0,"adr":0,"listingDate":1305820800000,"exchange":"SEHK","adjPreClose":11.95,"dividendRate":0.026946,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":0.408582,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":17.96,"timestamp":1765782000000,"preClose":18.05,"halted":0,"volume":10235700,"delay":0,"premium":"-40.28"}},"requestUrl":"/m/hq/s/02607","defaultTab":"news","newsList":[{"id":"2591616417","title":"上海医药(601607.SH)：硫酸羟氯喹片获得菲律宾药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616417","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616417?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:09","pubTimestamp":1765786182,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海上药中西制药有限公司(简称“上药中西”)生产的硫酸羟氯喹片收到菲律宾食品药品监督管理局颁发的药品注册证书，该药品获得批准上市。硫酸羟氯喹片主要用于类风湿关节炎、青少年慢性关节炎、盘状和系统性红斑狼疮、以及由阳光引发或加剧的皮肤疾病。本次硫酸羟氯喹片(200mg)获得菲律宾食品药品监督管理局的药品注册批文，标志着公司具备了在菲律宾市场销售该药品的资格，对公司拓展海外市场带来积极影响，并积累了宝贵的经验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","BK0196","BK0209","BK0020","601607","BK0175","BK0183","BK0099","BK0184","02607","BK0097","BK0187","BK0188","BK0028","BK0012"],"gpt_icon":0},{"id":"2591616286","title":"上海医药：盐酸索他洛尔片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616286","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616286?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:05","pubTimestamp":1765785951,"startTime":"0","endTime":"0","summary":"【上海医药：盐酸索他洛尔片通过仿制药一致性评价】上海医药公告，常州制药厂有限公司收到国家药监局颁发的《药品补充申请批准通知书》，盐酸索他洛尔片通过仿制药质量和疗效一致性评价。该药品主要用于转复和预防室上性心动过速、心房扑动、心房颤动、各种室性心律失常以及急性心肌梗死并发严重心律失常。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512153591706790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK0184","BK0012","BK1197","BK0020","02607","BK0097","601607","BK0028","BK0175","BK0187","BK0196","BK0209","BK0188","BK0099"],"gpt_icon":0},{"id":"2591613706","title":"官方公布，全国药店百强榜来了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2591613706","media":"药械VIP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591613706?lang=zh_cn&edition=full","pubTime":"2025-12-14 11:17","pubTimestamp":1765682256,"startTime":"0","endTime":"0","summary":"2024年，全国七大类医药商品销售总额29470亿元，扣除不可比因素同比增长0.6%。在药品零售方面，2024年全国前10位企业年销售总额1504亿元，占全国药品零售市场总额23.1%；前100位年销售总额2470亿元，占比38%。以批发为主的上市公司平均毛利率10.3%；平均费用率6.9%；平均净利润率2.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214114842a448ef73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214114842a448ef73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","BK1197"],"gpt_icon":0},{"id":"2590503970","title":"每日卖空追踪 | 上海医药 12月12日卖空量成交900股，卖空比例为0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590503970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590503970?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528230,"startTime":"0","endTime":"0","summary":"上海医药北京时间12月12日，涨1.53%，卖空量成交900股，较上一交易日减少91.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165328979e9844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165328979e9844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2590750313","title":"上海医药12月12日主力净流入384.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590750313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590750313?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527358,"startTime":"0","endTime":"0","summary":"12月12日, 上海医药股价涨1.53%，报收11.95元，成交金额3029.2万元，换手率0.28%，振幅2.12%，量比0.83。上海医药今日主力资金净流入384.8万元，上一交易日主力净流出71.3万元。该股近5个交易日下跌1.73%，主力资金累计净流入283.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1380.5万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162901979e8d7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162901979e8d7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","BK1197"],"gpt_icon":0},{"id":"2590541841","title":"全国药店百强榜来了！官方公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541841","media":"搜药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590541841?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:32","pubTimestamp":1765449175,"startTime":"0","endTime":"0","summary":"近日，国家商务部发布《2024年药品流通行业运行统计分析报告》。2024年，全国七大类医药商品销售总额29470亿元，扣除不可比因素同比增长0.6%。以批发为主的上市公司平均毛利率10.3%；平均费用率6.9%；平均净利润率2.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212021839a69a126a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212021839a69a126a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","BK1197"],"gpt_icon":0},{"id":"2590254184","title":"券商今日金股：4份研报力推一股（名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2590254184","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590254184?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:03","pubTimestamp":1765440183,"startTime":"0","endTime":"0","summary":"据证券之星数据库不完全统计，12月11日券商共给予8家A股上市公司“买入”评级。大参林最受券商关注，近一个月获国信证券、西南证券等4份券商研报关注，位居12月11日券商力推股榜首。需要指出的是，券商给予“评级”并不绝对预示着股价的上涨，“增持”或“买入”与否，其实都是机构对于股票的“一家之谈”。因此，券商金股在大多数程度上仅是用作投资参考意义的，投资者切不可盲目买入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116155495375259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121116155495375259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2590353543","title":"研报掘金丨中邮证券：维持上海医药“买入”评级，看好创新业务驱动成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2590353543","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590353543?lang=zh_cn&edition=full","pubTime":"2025-12-11 13:38","pubTimestamp":1765431532,"startTime":"0","endTime":"0","summary":"格隆汇12月11日｜中邮证券研报指出，上海医药商业板块稳健增长，Q3减值影响利润，看好创新业务驱动成长。2025Q1-3公司创新药业务实现销售收入407亿元，同比增长超过25%；进口总代业务实现销售收入276亿元，同比增长超过14%；器械大健康业务实现销售收入339.88亿元，同比增长超过4%。截至2025年9月30日，公司提交临床试验申请获得受理及进入后续临床试验阶段的新药管线共计57项，包括创新药管线45项。维持“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211133906a441a38c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211133906a441a38c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHPMY","02607"],"gpt_icon":0},{"id":"1190711405","title":"上海医药集团股份有限公司(02607)将于2026年02月06日派发中期股息每股0.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190711405","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190711405?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:42","pubTimestamp":1765356178,"startTime":"0","endTime":"0","summary":"上海医药集团股份有限公司于2025年12月10日发布公告，更新截至2025年6月30日止六个月的中期股息派发事宜，更新原因为除净日变更。本次每股将派发人民币0.12元股息。公司已于2025年12月9日获得股东批准，除净日为2025年12月29日，股权登记日为2025年12月31日，派息日定于2026年2月6日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"gpt_icon":0},{"id":"2590580791","title":"每日卖空追踪 | 上海医药 12月10日卖空量成交1300股，卖空比例为0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590580791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590580791?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355432,"startTime":"0","endTime":"0","summary":"上海医药北京时间12月10日，跌1.09%，卖空量成交1300股，较上一交易日减少95.78%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163648a72f4fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163648a72f4fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2590301278","title":"上海医药：子公司取得药品上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2590301278","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590301278?lang=zh_cn&edition=full","pubTime":"2025-12-10 15:53","pubTimestamp":1765353188,"startTime":"0","endTime":"0","summary":"南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587664274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0097","BK0028","BK0175","BK0099","BK0188","BK0020","02607","BK0184","BK0183","BK0209","BK0012","601607","BK0187","BK1197","BK0196"],"gpt_icon":0},{"id":"2590308537","title":"上海医药股东大会通过取消监事会及半年度分红等多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2590308537","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590308537?lang=zh_cn&edition=full","pubTime":"2025-12-10 13:17","pubTimestamp":1765343821,"startTime":"0","endTime":"0","summary":"中访网数据 上海医药集团股份有限公司于2025年12月9日召开2025年第二次临时股东大会。会议以现场结合网络投票方式审议并通过了全部四项议案。其中，关于取消监事会并修订《公司章程》及其附件的特别决议案获得高票通过，同意股份数占出席会议有效表决权股份总数的95.78%，远超三分之二门槛。此举意味着公司治理结构将从“三会一层”向“董事会中心”模式转变。备受关注的2025年半年度利润分配预案也获批准，同意票比例高达99.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251210/31855866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0183","BK0099","BK0188","BK0020","BK0196","BK0028","BK0209","601607","BK0187","BK0012","02607","BK0175","BK1197","BK0097","BK0184"],"gpt_icon":0},{"id":"2590312678","title":"上海医药(02607)将于2026年2月6日派发中期股息每10股1.3215港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590312678","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590312678?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:04","pubTimestamp":1765274665,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(02607)公布，将于2026年2月6日派发中期股息每10股1.3215港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","BK0012","BK0097","BK0028","BK0187","BK0188","BK0099","BK1197","BK0183","BK0184","BK0196","BK0020","BK0209","02607","BK0175"],"gpt_icon":0},{"id":"2589389393","title":"上海医药：氨磺必利口崩片纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589389393","media":"人民财讯","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589389393?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:02","pubTimestamp":1765180968,"startTime":"0","endTime":"0","summary":"人民财讯12月8日电，上海医药(601607)12月8日公告，公司下属公司上药中西的氨磺必利口崩片通过国家医保谈判，成功纳入《国家医保目录》。氨磺必利口崩片是赛诺菲（Sanofi）公司于1986年在法国上市的氨磺必利片的改良剂型，用于治疗成人精神分裂症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512083585282351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601607","BK0012","BK0097","BK0028","BK0187","BK0188","BK0099","BK1197","BK0183","BK0184","BK0196","BK0020","BK0209","02607","BK0175"],"gpt_icon":0},{"id":"2589233893","title":"上海医药：氨磺必利口崩片纳入国家医保目录 该药品境内暂无其他企业上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2589233893","media":"每日经济新闻","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589233893?lang=zh_cn&edition=full","pubTime":"2025-12-08 15:58","pubTimestamp":1765180734,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月8日，上海医药(601607.SH)公告称，公司下属上海上药中西制药有限公司的氨磺必利口崩片通过国家医保谈判，成功纳入《国家医保目录》，协议有效期为自2026年1月1日至2027年12月31日。截至本公告日，中国境内氨磺必利口崩片暂无其他企业上市。IQVIA数据库显示，2024年氨磺必利口服制剂的医院采购金额为1.68亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512083585276022.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512083585276022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0184","BK0028","BK0196","BK0209","BK0175","02607","601607","BK0187","BK0020","BK0183","BK0188","BK1197","BK0099","BK0097","BK0012"],"gpt_icon":0},{"id":"2589087717","title":"上海医药收回1.1亿元 终止与生诺生物新型抑酸剂合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2589087717","media":"中国经营报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589087717?lang=zh_cn&edition=full","pubTime":"2025-12-07 21:30","pubTimestamp":1765114201,"startTime":"0","endTime":"0","summary":"12月5日晚间，上海医药（601607.SH）发布公告，宣布其全资子公司上海上药信谊药厂有限公司（以下简称“上药信谊”）已正式终止与贵州生诺生物科技有限公司及其关联方关于新型抑酸剂X842项目的合作协议。根据双方签署的终止协议，贵州生诺方面已返还上海医药1.1亿元首付款及开发注册里程碑费用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512073584625889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK0020","BK0097","BK0187","BK0188","BK0196","BK1197","02607","BK0099","BK0184","BK0175","BK0012","601607","BK0028","BK0209"],"gpt_icon":0},{"id":"2589860452","title":"历时4年终无果 上海医药终止与生诺生物合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2589860452","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589860452?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:52","pubTimestamp":1764924759,"startTime":"0","endTime":"0","summary":"12月5日，上海医药（601607/02607）发布公告，宣布与贵州生诺生物科技有限公司的合作协议终止。该协议于2021年10月8日签署，涉及新型抑酸剂X842项目，允许公司全资子公司上药信谊获得该项目的独家生产和销售权。基于对外部市场的综合评估及各方经营发展规划的考虑，2025年11月18日，上药信谊与生诺生物达成了终止协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512053583869660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK1197","BK0099","BK0020","02607","BK0187","BK0209","BK0175","BK0188","BK0012","BK0196","BK0097","BK0028","601607","BK0184"],"gpt_icon":0},{"id":"2589814054","title":"每日卖空追踪 | 上海医药 12月05日卖空量成交1.04万股，卖空比例为0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589814054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589814054?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:30","pubTimestamp":1764923430,"startTime":"0","endTime":"0","summary":"上海医药北京时间12月05日，涨0.75%，卖空量成交1.04万股，较上一交易日减少83.01%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163434979180d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163434979180d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2589140538","title":"上海医药12月05日获主力加仓50.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589140538","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589140538?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922554,"startTime":"0","endTime":"0","summary":"12月05日, 上海医药股价涨0.75%，报收12.16元，成交金额5462.4万元，换手率0.49%，振幅0.99%，量比1.88。上海医药今日主力资金净流入50.6万元，上一交易日主力净流入341.6万元。该股近5个交易日上涨2.96%，主力资金累计净流入1383.7万元；近20日主力资金累计净流入2055.1万元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162126a7257fcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162126a7257fcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","02607"],"gpt_icon":0},{"id":"2589862429","title":"上海医药(601607.SH)：米诺地尔搽剂获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589862429","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589862429?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:05","pubTimestamp":1764921958,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药 发布公告，近日，公司下属上药东英(江苏)药业有限公司的米诺地尔搽剂收到国家药品监督管理局颁发的《药品注册证书》，该药品获得批准生产。米诺地尔搽剂最早由强生公司开发，2%规格于1988年在美国上市，5%规格于1997年在美国上市。2024年1月，上药东英就该药品向国家药监局提出注册申请并获受理。截至公告日，公司针对该药品已投入的研发费用约人民币656万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0188","02607","BK0175","BK0183","601607","BK0187","BK0209","BK0097","BK1197","BK0028","BK0184","BK0099","BK0012","BK0020","BK0196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shaphar.com.cn","stockEarnings":[{"period":"1week","weight":-0.0239},{"period":"1month","weight":-0.0319},{"period":"3month","weight":-0.0413},{"period":"6month","weight":0.0468},{"period":"1year","weight":-0.0826},{"period":"ytd","weight":-0.0361}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.0533},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0809},{"period":"1year","weight":0.2833},{"period":"ytd","weight":0.2776}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海医药集团股份有限公司是一家主要从事医药工业、分销与零售业务的中国公司。该公司的产品包括创新药、化学药、中药和罕见病药。该公司的产品主要用于心血管系统、消化道和新陈代谢、全身性抗感染、中枢神经系统、抗肿瘤和免疫调节剂、骨骼肌肉系统和呼吸系统等领域。另外，该公司还提供医药物流和仓储服务。该公司的产品销往中国国内和海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002977},{"month":2,"riseRate":0.571429,"avgChangeRate":0.01754},{"month":3,"riseRate":0.571429,"avgChangeRate":0.010833},{"month":4,"riseRate":0.5,"avgChangeRate":-0.0006},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.000668},{"month":6,"riseRate":0.533333,"avgChangeRate":-0.009981},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.012747},{"month":8,"riseRate":0.4,"avgChangeRate":0.004418},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014002},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.022135},{"month":11,"riseRate":0.466667,"avgChangeRate":0.029707},{"month":12,"riseRate":0.6,"avgChangeRate":-0.010639}],"exchange":"SEHK","name":"上海医药","nameEN":"SH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,02607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}